Immunosuppressive therapy for aplastic anemia: a single-center experience from western India

Immunosuppressive therapy (IST) with antithymocyte globulin (ATG) and cyclosporine A (CsA) is the first-line therapy for acquired aplastic anemia (AA) in those not suitable for bone marrow transplant. Horse ATG (hATG) is preferred for this purpose, but its use is often impeded by shortages and costs...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Hematol
Autors principals: Shah, Sandip, Jain, Preetam, Shah, Kamlesh, Patel, Kinnari, Parikh, Sonia, Patel, Apurva, Panchal, Harsha, Anand, Asha
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6334724/
https://ncbi.nlm.nih.gov/pubmed/30173288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-018-3487-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars